Australia Stock Exchange release from AVECHO BIOTECHNO : Improved Propofol TPM Formulation Passes Toxicology Study
03/11/2020 21:54
Australia Stock Exchange release from AVECHO BIOTECHNO AVE.AX : Improved Propofol TPM Formulation Passes Toxicology Study
Recent news on Avecho Biotechnology
See all newsBrief: Avecho Biotechnology Says Japanese Patent Granted For CBD Capsule
Brief: Avecho Biotechnology Seeks Trading Halt
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement